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ABSTRACT
Objective: The objective of this study is to evaluate pain and to assess if analgesic prescriptions are according to the World Health Organization guidelines.
Methods: The study was conducted in the Department of Surgery in a tertiary care hospital. Patients with age >18 years, of either sex, admitted to 
surgery ward were included in the study. Pain assessment was done using a visual analog scale and McGill questionnaire. Information obtained from 
case paper sheets was recorded, such as name of analgesics, the generic name of prescribed analgesics, dosage, route of administration, frequency, 
number of analgesics per prescription, and non-pharmacological techniques. Data generated from the questionnaire were entered into an Excel sheet, 
and percentages were calculated.
Results: A total of eight different analgesics were prescribed in the study group. Paracetamol was the maximally prescribed drug (40%). In 48% of 
cases, antacids were given along with analgesics. A majority of analgesics were prescribed in generic names (52%). No drug was prescribed to almost 
18% cases even though the pain intensity was of mild-to-moderate intensity.
Conclusion: Commonly prescribed drugs were paracetamol + tramadol. Prescription pattern of analgesics is partially deviating from standard 
guidelines. Generic names were written in the majority of prescriptions, which is in accordance with standard prescription writing.
Keywords: Pain, Analgesics, Observational study.
INTRODUCTION
Pain is one of the most common symptoms for which patients look for 
medical attention and is also important in making the correct diagnosis. 
The International Association for the Study of Pain defines pain as “an 
unpleasant sensory and emotional experience associated with actual 
or potential tissue damage or described in terms of such damage” [1]. 
Pain is always a subjective experience and a sensation perceived by 
the patient. Uncontrolled pain gives a constant feeling of discomfort to 
the patient, which affecting his/her psychological and functional well-
being [2].
Patients admitted to the surgery ward suffer from diverse pain, which 
is managed medically or surgically. In patients’ undergone surgical 
procedure, the purpose of post-operative pain (POP) control is to 
maintain functional abilities, as well as physical and psychological 
wellbeing of the patient. This is achieved by providing safe and 
effective control of acute pain immediately after the intervention. Pain 
in recently operated patients refrains them from activity leading to 
weakness, delayed rehabilitation, and ambulation which may further 
lead to increased risk of deep vein thrombosis [3]. Adequate control of 
pain is essential to enhance their quality of life, ultimately proceeding 
to faster recovery [4].
In the year 1996, the American Pain Society introduced the phrase 
“pain as the 5th vital sign” [5]. This concept was introduced to create 
an awareness of pain treatment among healthcare professionals. 
This initiative emphasizes that pain assessment is as important as an 
assessment of the standard four vital signs - pulse, blood pressure, 
temperature, and respiration, and every patient should be assessed 
for pain every time these vital signs are measured. Pain assessment 
is the first and important step of pain management. There are various 
standard scales used for pain assessment of which few are patient’s 
scales and few are observer scale. Timely assessment will help us to 
determine the change in pain intensity score as a response to treatment 
and to decide if the given analgesic is effective enough or not. One of 
the objectives of the National Drug Policy is to promote the rational 
use of drugs by prescribers, dispensers, and consumers. In developing 
countries, inappropriate analgesic prescribing has been identified 
among healthcare facilities.
Therefore, this study is planned to obtain the data on pain management 
and type and appropriateness of analgesics prescribed in a tertiary care 
hospital.
METHODS
The study was approved by the Institutional Ethics Committee of Bharati 
Vidyapeeth Medical College, Pune, Maharashtra (DCGI Reg. No. ECR 518 
– BVDU/MC/E51). This trial has been registered with the Clinical Trial 
Registry of India (Registration No. CTRI/2018/04/013499).
Study site
The study was conducted in the Department of Surgery in a tertiary 
care hospital.
Study design
Prospective, observational, cross-sectional, unicentric, and descriptive 
type of study.
Study period
Two months, from March 2017 to May 2017.
Study sample
Patients with age >18 years, of either sex, admitted to surgery ward 
during the same period and willing to participate in the study.
© 2018 The Authors. Published by Innovare Academic Sciences Pvt Ltd. This is an open access article under the CC BY license (http://creativecommons. 
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Written consent was taken after giving complete information of study. 
For assessment of pain, a data collection form was designed and 
validated. Data and information were collected from patients and from 
case papers within 24 h of admission.
Pain assessment
There are various standard scales used for pain assessment of which few 
are patient’s scales and few are observer scale. We used visual analog 
scale (VAS) and McGill Questionnaire for the pain assessment.
VAS
The VAS is a one-dimensional measure of pain intensity. It is generally 
regarded as a valid and reliable tool for pain assessment and is the most 
widely used scale for the pain assessment [6]. It is usually 10 cm in length 
and has a marker that the patient moves to the point, indicating his/her 
pain of intensity. For pain intensity, the scale is anchored by “no pain” 
at 0 and “worst imaginable pain” at 10. The following cut points on the 
pain VAS have been recommended: no pain (0–0.4 cm), mild pain (0.5–
4.4 cm), moderate pain (4.5–7.4 cm), and severe pain (7.5–10 cm) [7].
McGill pain questionnaire (MPQ)
MPQ is a multi-dimensional pain questionnaire which is designed 
to measure the sensory, affective, and evaluative aspects of pain and 
pain intensity. VAS provides data on the intensity of pain, but it does 
not give any data on the qualities of pain. MPQ is a valid and reliable 
tool that evaluates both the quality and quantity of pain through the 
use of unique pain descriptors using a questionnaire which is easy to 
understand by patients [8].
This questionnaire has the following three sections broadly:
1. What does your pain feel like?
2. How strong is your pain?
3. How does your pain change with time?
The first section with heading as “What does your pain feel like?” 
describes quality or characteristic of pain. The second section asking 
“How strong is your pain?” describes the present pain intensity and 
overall pain experience. The third section with heading as “How does your 
pain change with time?” is useful in assessing the pattern of pain. The 
total pain rating index score is obtained by summing the scores obtained 
from different subscales. First part includes anatomical location of pain 
and recording quality of pain using different descriptors. Descriptor 1-11 
represents sensory dimension of pain, and descriptor 12-15 represent 
affective dimension of pain. Second part includes recording of present 
pain intensity using visual analog scale, and assessment of overall pain 
experience. Last part includes recording of pattern of pain. All these 
scores are added together to get total pain rating index. As for the MPQ, 
there are no established critical cut points, a higher score indicates worse 
pain. It can be used to monitor the pain over time and to determine the 
effectiveness of any intervention. Timely assessment will help us to 
determine the change in pain intensity score as a response to treatment 
and to decide if the given analgesic is effective enough or not. No training 
is required to score and interpret both VAS and MPQ.
Information obtained from case paper sheets which mainly includes 
details such as name of analgesics as written by the surgeon, generic 
name of prescribed analgesics (opioid and non-opioid), dosage, route 
of administration, frequency and duration of administration, number 
of analgesics per prescription, total number of drugs prescribed, non-
pharmacological techniques if advised, and multimodal anesthesia if 
prescribed was noted down. Patients were followed up on day 7 and 
15. If patients were discharged of hospital, follow up was done on 
telephone. Similar details were noted on follow-up visits.
Statistical analysis
Data generated from the questionnaire were coded, entered, and 
statistical analysis was done using Microsoft Excel 2010. Results were 
expressed in percentage. Frequency distribution tables and chart were 
prepared from the analysis.
RESULTS
In this study, the male-to-female ratio was almost similar. About 48% 
of patients were male and 52% of patients were female. The study 
included patients ranging from 20 years to 80 years of age. Maximum 
patients were from age group 20–40 years. The mean age was 43 years. 
Table 1 shows disease-wise distribution of patients. Many patients 
were admitted for the pain arising out of cancer. Next to it were patients 
with renal calculi and so on.
Fig. 1 shows overall analysis of all the prescriptions. Among them, 
non-steroidal anti-inflammatory drugs (NSAIDs) were preferred over 
opioid analgesics. In single-drug prescriptions, paracetamol was the 
maximum prescribed analgesic (85%) followed by diclofenac (27%) and 
ibuprofen (4%). About 11% prescriptions contained opioid analgesic, 
i.e., tramadol. To 8% of cases, no analgesic was prescribed.
Overall, opioid analgesics were prescribed only in 27% cases (Fig. 2). 
Fig. 3 shows a graphical representation of combinations of analgesics 
in prescriptions. Among combinations, paracetamol was used most 
commonly. Maximum combinations (72%) were of paracetamol 
+ diclofenac. Followed to it was paracetamol + ibuprofen (12%), 
paracetamol + tramadol (14%), and least used combination was 
diclofenac + tramadol (2%).
Fig. 4 shows the distribution of drugs according to the branded and generic 
name. Paracetamol was the only prescribed with the generic name in 
83 cases, whereas all remaining drugs such as diclofenac (13), tramadol (7), 
ibuprofen (0), and other drugs (0) were prescribed with the brand name.
Fig. 5 shows that 74% of cases received acid-reducing drugs along with 
analgesics. Of these 74% cases, who were receiving acid-reducing drugs 
as an adjuvant, were majorly belonging to NSAIDs class. Proton pump 
inhibitors and H2 blockers were the two classes of drugs used for the 
purpose of inhibition of acid secretion. Among them, rantac (ranitidine) 
and Pan-D (pantoprazole–domperidone) were prescribed maximally.
DISCUSSION
Pain is the warning signal of the underlying disease. When it is unbearable 
and interferes with daily activities, it becomes a compelling reason for 














Fig. 1: Percentages of analgesics prescribed as a single drug
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seeking medical attention [9]. Surgery wards also have patients operated 
for various ailments. It is essential to control POP in such patients to 
maintain their functional abilities as well as physical and psychological 
well-being [10]. Uncontrolled pain can have several physical and 
psychological ill effects and if left untreated can further affect almost 
all body systems. Pain in recently operated patients refrains them from 
activity leading to weakness, delayed rehabilitation, and ambulation 
which may further lead to increased risk of deep vein thrombosis [11]. 
Adequate control of pain in such patients can enhance their quality of 
life, ultimately proceeding to faster recovery [3] this will further help 
in reducing time spent in the hospital, readmissions for further pain 
management and development of chronic pain. One of the objectives 
of the National Drug Policy is to promote the rational use of drugs 
by prescribers, dispensers, and consumers. In developing countries, 
inappropriate analgesic prescribing has been identified among healthcare 
facilities. Undertreatment of pain will let the patient suffer from pain and 
with overtreatment patient will unnecessary be exposed to the adverse 
effects of drugs. Therefore, this one-time study was planned to obtain the 
data on pain management and type and appropriateness of analgesics 
prescribed in a tertiary care hospital. The study of prescribing pattern 
is a significant constituent of a medical audit which helps in monitoring, 
evaluating, and making required modifications in the prescribing 
practices to attain a rational medical care. The prescription audit is an 
important part of drug utilization studies. Inappropriate use of analgesics 
may either cause inadequate pain relief or increased incidence of adverse 
effects, habituation, abuse potential, and the emergence of tolerance 
requiring an increased amount of drugs. Both the situations, inadequate 
control and unnecessary prescription of analgesics can have a negative 
influence on the health of the patient, and hence, it is utmost important 
to give adequate analgesia with appropriate analgesics.
Table 1 includes patients suffering from the different ailments, such as 
renal calculi, appendicitis, and fractures, and admitted in surgery ward 
for the treatment were included in the study. The highest number of 
patients was from 20 to 40 years age group. Lowest number of patients 
was from above 80 age group. Mean age of patients was 43 years. The 
male-to-female ratio in the study was almost similar.
Paracetamol, diclofenac, ibuprofen, and tramadol were the most 
commonly used analgesics in the present study. Majority of them 
belong to NSAIDs group. In the maximum number of cases, paracetamol 
was given by injectable route. Furthermore, in case of combinations 
of an oral and a parenteral analgesic, parenteral analgesic was given 
as the starting dose and then oral analgesic as the maintenance dose. 
Mohammed et al. stated that paracetamol was the most commonly 
prescribed NSAID, which is similar to the findings that we have 
obtained [12]. Similar results are seen from a prescription study which 
was done in Medicine department in Dhaka, Bangladesh, by Rahman 
et al., where paracetamol was the most common prescribed followed 
by diclofenac [13]. However, from some studies, different observations 
are seen as, in a study done by Paul et al. [14] and Seager et al. [15], 
Ibuprofen was the most common analgesic prescribed, may be owing to 
its less gastric adverse effects against other NSAIDs [16]. This deviates 
from the results obtained from our study. The analgesics prescribed 
were found to be appropriate for the indications. However, in few 
conditions, it was mild analgesic for moderate pain. The duration for 
which the analgesics were prescribed was also found to be appropriate. 
Opioid analgesic was found to be prescribed in only 11% of cases.
The choice of analgesics depends on the severity of pain. According to the 
severity for mild-to-moderate pain, single analgesics are sufficient, but for 
moderate-to-severe pain two or more than two analgesics are required. 
This is also dependent on the efficacy and potency of the analgesic.
There were 12 cases even though complained of pain did not receive any 
analgesic drug. Nearly 50% (6 cases) of cases were having the moderate 
Fig. 2: Percentage of cases received opioid analgesic
Fig. 3: Percentage of drug used in combinations
Fig. 4: Distribution of drug used as branded and generic
Fig. 5: Percentages of cases given acid-reducing drug
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intensity of pain, and 33% (4 cases) were in severe pain. According to 
the World Health Organization (WHO) analgesic ladder guideline, all 
those patient should have received NSAID + weak opioid drug, but no 
analgesic drug was prescribed. This shows the slight deviation in the 
use of analgesic from the standard guideline.
Combination of analgesics plays an extremely valuable role in the 
management of pain. Drugs used in combinations were paracetamol 
with diclofenac, ibuprofen, and even with tramadol. Paracetamol with 
Ibuprofen shows a synergistic analgesic effect, and this combination 
is routinely used for the treatment of pain. Overall paracetamol was 
used most frequently, may be because of adequate analgesic action 
with additional antipyretic effect and least number of side effects, 
especially no incidence in causing GI side effects, providing better 
its safety profile among all NSAIDs that too at very less cost. Opioid–
acetaminophen combinations are recommended in the WHO analgesic 
ladder for moderate-to-severe intensity of pain [17]. Tramadol 
with acetaminophen combination provides the potential benefits 
by increasing efficacy and reducing the adverse effects. Both the 
component have a different mechanism of action and the combination 
shows a synergistic effect in pain relief [18]. The goal of the therapy is to 
facilitate patient compliance, simplify prescribing and improve efficacy 
without increasing adverse effects and is achieved with combination 
therapy [19]. A majority of the analgesics were prescribed correctly 
as regards the strength, frequency, and duration of use. Prescribing 
less expensive generic drugs is one method of curtailing prescription 
drug expenditures. In this study, generic paracetamol was prescribed 
in 83 (65 %) while branded paracetamol was prescribed in 44 (35%). 
Diclofenac with generic name prescribed in 13 (33%) and branded 
name in 27 (67%). Tramadol prescribed mostly with brand name only. 
Drugs when prescribed with generic name definitely help to reduce the 
cost of the treatment. In the present study, it is in favor of the same and 
supporting national drug policy.
Analgesics used in the study were from both the groups NSAIDs and 
opioids. Paracetamol and diclofenac was the most commonly used 
drug in this study. NSAIDs are known to produce adverse effects 
such as gastric irritation, nausea, vomiting, ulceration, bleeding, and 
occult blood loss in stools. To minimize these side effects, NSAIDs are 
prescribed with acid-reducing agents. Proton pump inhibitors and 
H2 blockers were prescribed in 74% of cases in the present study. 
However, according to the American College of Gastroenterology, only 
the patients at high risk for hemorrhage and perforation with aspirin 
and other NSAID-induced ulcers should be considered for prophylaxis. 
The commonly used drugs for this purpose are misoprostol and proton 
pump inhibitors [20]. Patients with prior history of the gastrointestinal 
event (ulcer and hemorrhage), age above 60 year those who require 
high dosages of NSAIDs, those who are taking corticosteroids and 
anticoagulants concurrently are considered as the high-risk patients 
who require the gastro-protective agents with NSAIDs. There are 
various adverse effects of long-term PPI therapy as decreased 
absorption of calcium, magnesium, Vitamin B 12, etc. this may lead 
to significant reduction in bone mineral density in elderly causing 
increased fracture risk [21]. Hence, PPI therapy should be personalized 
and given based on indications. H2 receptor antagonists have been 
shown to prevent only duodenal ulcer, and therefore, they have limited 
value in the prophylaxis of NSAIDs-induced gastric ulcers and hence not 
recommended [22]. However, in the present study, it was prescribed for 
prophylaxis which cannot be justified.
The study was performed to analyze the use of analgesics by surgeons 
in patients of surgery ward. According to the WHO analgesic ladder 
depending on the intensity and type of pain appropriate analgesics 
should be prescribed. In the present study, pain was assessed with VAS 
and MPQ, and the data about drug use was obtained from case sheets. It 
was encouraging that in the majority of cases analgesics were prescribed 
in accordance with the WHO guidelines. In very few cases, no analgesic 
was given even though pain was mild-to-moderate intensity. This 
should be addressed to reduce the patient’s sufferings. Inappropriate 
use of acid-reducing agents was observed with the analgesics which can 
be reduced. From the study, it was observed that in most of the cases 
drug combinations were used which enhanced the efficacy and reduced 
adverse effects because of synergistic combinations of analgesics. 
Most of the drugs were prescribed with the generic names which were 
following the National drug policy.
CONCLUSION
Our study showed that pain management in the tertiary healthcare 
center was largely in accordance with the National Drug Policy and 
Standard treatment guidelines. Commonly prescribed drugs were 
paracetamol and diclofenac combination. A majority of prescriptions 
were with generic names which were according to the National drug 
policy. In very few cases, no analgesic was given even though pain was 
of mild-to-moderate intensity. This should be addressed to reduce 
the patient’s sufferings. In most of the cases, analgesics were given 
with acid-reducing agents. Measures are required to prevent the 
irrational use of acid-reducing agents. In a very few cases, prescription 
pattern of analgesics was slightly deviating from standard guidelines. 
Nevertheless, this can be upgraded by conducting training and 
educational programs.
LIMITATIONS
Our study was carried out in a single tertiary care hospital in India and 
does not represent all the surgeons in India. In addition, the outpatients 
and patients from different departments were not considered. An 
attempt should be made to carry out such studies with larger geographic 
coverage, with a bigger sample size, and at multiple centers. This will 
invariably increase the sample size and will give us a broader picture of 
the plight of the entire state or the entire country.
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